55.02
price up icon10.05%   5.065
 
loading

Finanzdaten der Celcuity Inc-Aktie (CELC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
21.80%
44.01
36.13 36.43 30.06 24.28
Operating Income/Loss
21.80%
-44.01
-36.13 -36.43 -30.06 -24.28
Nonoperating Income/Loss
45.72%
-1.259
-0.864 - - -
Income/Loss From Continuing Operations Before Tax
22.36%
-45.27
-37.00 -36.65 -29.79 -23.72
Income/Loss From Continuing Operations After Tax
22.36%
-45.27
-37.00 -36.65 -29.79 -23.72
Net Income/Loss
22.36%
-45.27
-37.00 -36.65 -29.79 -23.72
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.42%
43.66
43.05 1.1498 42.79 38.44
Diluted Average Shares
1.42%
43.66
43.05 1.1498 42.79 38.44
Basic Earnings Per Share
20.93%
-1.04
-0.86 -0.87 -0.70 -0.62
Diluted Earnings Per Share
20.93%
-1.04
-0.86 -0.87 -0.70 -0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.13
price up icon 1.37%
$83.84
price down icon 1.19%
$24.59
price down icon 0.87%
$101.77
price down icon 1.19%
$135.20
price up icon 0.50%
biotechnology ONC
$300.54
price down icon 0.03%
Kapitalisierung:     |  Volumen (24h):